PHILADELPHIA, May 6, 2021 /PRNewswire/ -- IntegriChain,
delivering Life Sciences' only comprehensive data and business
process platform for market access, today announced that
Jen Sharpe, a Gross-to-Net (GTN)
leader at the company, will present at Informa's upcoming
Bio/Pharma CFO Digital Week. Sharpe is a GTN and Life Sciences
accounting expert and runs the Revenue Analytics Collaborative, a
network of 800+ business and financial professionals focused on
Commercial, Government, GTN, and Trade/Channel data, processes, and
systems. The presentation will focus on GTN digital transformation
case studies and will feature GTN leaders Tina Knell from Bridgebio and Kary Callahan from Paratek. IntegriChain is a
sponsor of the virtual conference, which runs May 11-13.
"Life Sciences manufacturers recognize critical data gaps in
their gross-to-net systems and processes," said Sharpe. "Innovative
teams such as those at Bridgebio and Paratek are tapping into the
value of a unified data platform and automated GTN systems that
deliver a single accurate, complete, and credible version of
financial truth to all stakeholders, eliminating spreadsheet toil
and freeing up their expertise to focus on driving the
business."
Case Study: Real World GTN Transformation using Data and
Analytics
May 13 10 am
- Visualize successful GTN management on a unified data
platform
- Improve GTN accruals and forecasting with greater visibility
into market access data and assumptions
- Drive business with data digitalization and visualization with
key metrics and trend analyses
- Gain confidence in the GTN forecasts with near real-time access
to data to increase efficiency and company-wide collaboration
About IntegriChain's GTN Solutions
IntegriChain
offers a full suite of GTN Solutions, including:
GTN Accrual Management. An end-to-end solution for
Market Access and Finance departments, pre-configured for all
standard line items with robust out-of-the-box accrual
methodologies, including inventory and pipeline adjustments to
accruals, balance sheet reconciliation to ERP systems, and true-up
functionality.
GTN Accrual Forecasting. Based on industry-standard
forecast methodologies configured for each liability line item with
the ability to execute multiple scenario analyses for forecasts
along with functionality to compare scenarios to improve forecast
accuracy, GTN modeling, and financial close efficiency.
GTN Analytics. Delivering visibility to comprehensive
market access datasets that power the accuracy of GTN accruals and
forecasting processes, best practices GTN reports and metrics, and
visualizations of GTN trends that allow for better accrual and
net-price predictability and decision-making.
GTN Advisory. IntegriChain industry experts routinely
advise manufacturers on GTN readiness for launch, GTN process
assessments, and GTN market analysis.
About IntegriChain
IntegriChain is Life Sciences'
data and application backbone for patient access and therapy
commercialization. More than 250 manufacturers rely on
IntegriChain's ICyte Platform to orchestrate commercial and
government payer contracting, patient services, and distribution
channels. ICyte is the first and only platform that unites the
financial, operational, and commercial data sets required to
support therapy access in the era of specialty and precision
medicine. With ICyte, Life Sciences innovators are digitalizing
labor-intensive processes – freeing up their best talent to
identify and resolve coverage and availability hurdles and to
manage pricing and forecasting complexity. IntegriChain is backed
by Accel-KKR, a leading Silicon Valley technology private equity
firm. The company is headquartered in Philadelphia, PA, with offices in Ambler, PA; Somerset, NJ, Raleigh, NC, and Pune, India. For more information, visit
www.integrichain.com, or follow us on Twitter
@IntegriChain and LinkedIn.
Contact
IntegriChain: Jennifer Guinan, Sage Strategic Marketing,
610.410.8111, Jennifer@sagestrat.com
View original
content:http://www.prnewswire.com/news-releases/integrichain-gross-to-net-expert-jen-sharpe-to-speak-at-informas-biopharma-cfo-digital-week-301285736.html
SOURCE IntegriChain